Anteris Technologies Global Corp. has announced a private placement with Covidien Group S.à r.l., a wholly owned subsidiary of Medtronic plc. Under the agreement, Anteris will issue and sell 15,652,173 shares of its common stock at a price of $5.75 per share, raising approximately $90 million in gross proceeds before fees and expenses. The company plans to use the net proceeds, along with funds from a concurrent underwritten offering, to support its growth and advance its clinical strategy. As part of the transaction, Anteris will enter into a registration rights agreement, granting the investor the right to require registration and sale of the shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Anteris Technologies Global Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-26-001938), on January 22, 2026, and is solely responsible for the information contained therein.